Biosimilars: To Switch or Not to Switch?

The pros and cons of using biosimilar medications shaped the “Great Debate” at this year’s ACR/ARHP Annual Meeting.

Source: ConsultantLive - November 7, 2017 Category: Internal Medicine Authors: Mariah Zebrowski Leach, JD, MS Tags: Rheumatoid Arthritis Rheumatic Diseases Source Type: news